Texas · Nonprofit
FOUNDATION FOR CARDIOVASCULAR RESEARCH AND INNOVATIONS
FOUNDATION FOR CARDIOVASCULAR RESEARCH AND INNOVATIONS (Texas) receives grants from 1 organization whose IRS filings report $14,000 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($14,000). 0 of them have funded it in more than one year, and 100% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2023
- $0
- Funders on record
- 1
- Grants received
- $14k
- Net assets
- $6k
What Foundation for Cardiovascular Research and Innovations does
Program
Conducting clinical research, supporting provider training, and developing patient education tools in the field of cardiovascular disease treatment and prevention
$0 spent
The program described on its FY2023 Form 990-PF.
The organization over time
Each line starts at 100 in 2018, so what you read is the shape rather than the size: 150 means half as much again as 2018, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2021 to 2022, from $2k to $6k (+236%).
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
Grant support over time, funder by funder — shade shows the grant size each year.
1 of 1 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 100% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of FOUNDATION FOR CARDIOVASCULAR RESEARCH AND INNOVATIONS’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
100% of FOUNDATION FOR CARDIOVASCULAR RESEARCH AND INNOVATIONS's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Too little is directly attributable to place on a map.
Funder states come from each funder’s own filing. $14k arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
FOUNDATION FOR CARDIOVASCULAR RESEARCH AND INNOVATIONS has grown faster than three-quarters of the 7,317 philanthropy nonprofits its size.
this organization peer median middle 50% of peers· 7,317 philanthropy nonprofits under $100k, FY2023
Organizations like FOUNDATION FOR CARDIOVASCULAR RESEARCH AND INNOVATIONS
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Texas
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Screen this organization
A dated, signed PDF of the compliance screen for FOUNDATION FOR CARDIOVASCULAR RESEARCH AND INNOVATIONS: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds FOUNDATION FOR CARDIOVASCULAR RESEARCH AND INNOVATIONS?
- FOUNDATION FOR CARDIOVASCULAR RESEARCH AND INNOVATIONS (Texas) receives grants from 1 organization whose IRS filings report $14,000 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($14,000). 0 of them have funded it in more than one year, and 100% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does FOUNDATION FOR CARDIOVASCULAR RESEARCH AND INNOVATIONS have?
- IRS filings report 1 organization giving $14,000 in grants to FOUNDATION FOR CARDIOVASCULAR RESEARCH AND INNOVATIONS.
- Who is the largest funder of FOUNDATION FOR CARDIOVASCULAR RESEARCH AND INNOVATIONS?
- FIDELITY INVESTMENTS CHARITABLE GIFT FUND is the largest funder on record, with $14,000 in grants. The full list of funders is on this page.
- How can an organization like FOUNDATION FOR CARDIOVASCULAR RESEARCH AND INNOVATIONS find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Texas. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds Foundation for Cardiovascular Research and Innovations →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2023 (financials across 2018–2023), and the filings of 1 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing